• For Researchers
• Health & Medicine

Making the most of your ‘eureka’ moment: getting from the science to the clinic

How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset

22 September 2021

• For Researchers

A celebration of peer review

As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees

21 September 2021

• Science & Technology
• Health & Medicine

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment. Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

21 September 2021

• For Researchers
• Science & Technology

How cancer hijacks cell death: a new view of metastasis

Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance. Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance.

17 September 2021

• Science & Technology

The Galleri multi-cancer blood test: What you need to know

There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test. There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.

13 September 2021

• For Researchers

Speaking a thousand words – how a cancer image collection is set to improve AI diagnosis

Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection

8 September 2021

• For Researchers

Kinder and more effective - why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

3 September 2021

• Science & Technology
• Health & Medicine

Cancer Research UK reports record levels of investment in its spinouts

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

24 August 2021

• For Researchers

The (un)usual suspects – how early detection research embraces interdisciplinary science

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

20 August 2021

• Science & Technology
• Health & Medicine

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

13 August 2021

• For Researchers

On your marks, get set… start-up!

Explore three of the latest companies to come out of one of our entrepreneurial programmes. Explore three of the latest companies to come out of one of our entrepreneurial programmes.

13 August 2021